Infectious mononucleosis: recognizing the condition, 'reactivating' the patient.

Area of Science:

• Infectious Diseases
• Virology
• Immunology

Background:

• Infectious mononucleosis (IM) is primarily caused by a two-step Epstein-Barr virus (EBV) infection.
• Diagnosis often relies on heterophil antibody detection, though newer viral antigen tests are available.

Purpose of the Study:

• To outline the diagnostic approaches and management strategies for infectious mononucleosis.
• To discuss the specific considerations for athletes recovering from IM and returning to sports.

Main Methods:

• Review of diagnostic methods for infectious mononucleosis, including serologic tests.
• Analysis of general management principles and rare complications like splenic rupture.
• Examination of recovery timelines and return-to-sport guidelines for athletes.

Main Results:

• Heterophil antibody rapid kit tests are typically sufficient for diagnosing IM.
• Management is primarily supportive; splenic rupture is rare and treatable with early diagnosis and splenectomy.
• Athletes generally recover faster than nonathletes, with return to contact sports contingent on spleen normalization (3-6 months for elite athletes).

Conclusions:

• Early diagnosis and supportive care are key for managing infectious mononucleosis.
• Splenic integrity is crucial for athletes, necessitating careful monitoring and a phased return to physical activity.